S Split Corp. Announces Automatic Term Extension and Special Retraction

Written by Customer Service on October 29, 2021. Posted in Public Companies.

TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) — (TSX: SBN; SBN.PR.A) S Split Corp. (the “Fund”) announced today that the term of the Fund is being extended automatically for an additional seven-year period beyond the November 30, 2021 termination date to November 30, 2028 as provided for in its articles of incorporation. In connection with the automatic extension of the term, holders of Class A shares and Preferred shares have a special retraction right (“Special Retraction Right”) to permit holders of such securities to retract such shares on November 30, 2021 on the terms on which such shares would have been redeemed had the term of the Fund not been extended. Retraction payments for Class A shares and Preferred shares tendered pursuant to the Special Retraction Right will be made no later than 10 business days following the retraction...

Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021

Written by Customer Service on October 29, 2021. Posted in Public Companies.

HAMILTON, Bermuda, Oct. 29, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Monday, November 1, 2021, at 8:30 a.m. Eastern Time to report its third quarter 2021 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours of the event. The conference call can be accessed by dialing (866) 614-0636 (U.S. and Canada) or (409) 231-2053 (international) using conference ID number 1699563. About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients...

MYR Group Inc. to Attend Baird 2021 Global Industrial Virtual Investor Conference

Written by Customer Service on October 29, 2021. Posted in Public Companies.

HENDERSON, Colo., Oct. 29, 2021 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and western Canada, announced it will attend Baird’s 2021 Global Industrial Conference. MYR Group’s Chief Executive Officer, Rick Swartz, and Chief Financial Officer, Betty Johnson, will virtually meet with institutional investors during the conference on Tuesday, November 9, 2021. This event is only available to Baird’s clients. About MYR Group Inc.MYR Group is a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets throughout the United States and western Canada who have the experience...

Heritage Southeast Bancorporation, Inc. and VyStar Credit Union Extend Purchase Agreement

Written by Customer Service on October 29, 2021. Posted in Mergers And Acquisitions.

ATLANTA, Oct. 29, 2021 (GLOBE NEWSWIRE) — Heritage Southeast Bancorporation, Inc. (“HSBI”) announced today that HSBI, Heritage Southeast Bank and VyStar Credit Union (“VyStar”) have mutually agreed to extend the time available to obtain regulatory approvals, satisfy other closing conditions and prepare for a smooth transition of HSBI’s business to VyStar, by waiving their respective rights to terminate the purchase agreement on or after December 31, 2021, until February 28, 2022. HSBI, Heritage Southeast Bank and VyStar each continue to pursue regulatory approvals from the FDIC, the NCUA, the Georgia Department of Banking and Finance and the Florida Office of Financial Regulation. While the parties continue to work toward closing the proposed business combination in 2021, the parties recognize that the timing of regulatory approval...

FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia

Written by Customer Service on October 29, 2021. Posted in Public Companies.

Scemblix provides much-needed and long-awaited new option for patients with chronic myeloid leukemia (CML) who suffer with intolerance or inadequate response after at least two previous tyrosine kinase inhibitor (TKI) treatments1 In the pivotal Phase III ASCEMBL trial, Scemblix demonstrated significant and clinically meaningful superiority in major molecular response (MMR) rate vs. Bosulif®* (bosutinib) (25% vs. 13%) at 24 weeks, and more -than -three times lower discontinuation rates due to side effects (7% vs. 25%)2,3 Additional Phase I data in patients with CML with the T315I mutation supported the FDA approval for a second indication in this patient population4 With a new mechanism of action known in scientific literature as a STAMP inhibitor and clinical trials across treatment lines – including in the first-line setting –,...

Exela Technologies, Inc. to Host Third Quarter 2021 Financial Results Conference Call

Written by Customer Service on October 29, 2021. Posted in Public Companies.

IRVING, Texas, Oct. 29, 2021 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA), a global business process automation (“BPA”) leader across numerous industries, will host a conference call with the financial community to discuss results for the third quarter 2021 at 2:00 p.m. ET on November 5, 2021. Exela will issue a press release reporting its results before the start of the call. Hosting the call and reviewing the results will be Ron Cogburn, Chief Executive Officer, and Shrikant Sortur, Chief Financial Officer. Following the review, there will be a question and answer session. The conference call will be broadcast live on Exela’s Investor Relations website at http://investors.exelatech.com. Third Quarter 2021 Results Webcast and Call Access Information Date: November 5, 2021 Time: 2:00...

Deep Medicine Acquisition Corp. Completes Upsized $126,500,000 Initial Public Offering, Including Full Exercise of Over-Allotment Option

Written by Customer Service on October 29, 2021. Posted in Public Companies.

New York, NY, Oct. 29, 2021 (GLOBE NEWSWIRE) — Deep Medicine Acquisition Corp. (Nasdaq: DMAQU) (the “Company”) today announced the closing of its upsized initial public offering of 12,650,000 units at a price to the public of $10.00 per unit, which includes 1,650,000 units issued pursuant to the underwriters’ exercise of over-allotment option in full, with the offering raising gross proceeds of $126,500,000. The units commenced trading on Wednesday, October 27, 2021, on The Nasdaq Global Market (“Nasdaq”) under the symbol “DMAQU.” Each unit issued in the initial public offering consists of one share of Class A common stock and one right to receive one-tenth of one share of Class A common stock upon the consummation of the Company’s initial business combination. Once the securities comprising the units begin separate trading, the...

AMERICA’S CAR-MART, INC. SCHEDULES RELEASE OF SECOND QUARTER 2022 RESULTS AND CONFERENCE CALL

Written by Customer Service on October 29, 2021. Posted in Public Companies.

Rogers, Arkansas, Oct. 29, 2021 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2022 second quarter financial results on Tuesday, November 16, 2021, after the market closes. Senior management will hold a conference call on Thursday, November 18, 2021 at 11:00 a.m. (Eastern). A live audio of the conference call will be accessible to the public by calling (877) 776-4031, conference ID #1075918. International callers should dial (631) 291-4132. Callers should dial in approximately 10 minutes before the call begins. A conference call replay will be available two hours following the call for thirty days and can be accessed by calling (855) 859-2056, conference ID #1075918; International callers should dial (404) 537-3406. A webcast of the conference call will also be available on...

ADT To Release Third Quarter 2021 Results On Tuesday, November 9, 2021

Written by Customer Service on October 29, 2021. Posted in Public Companies.

BOCA RATON, Fla., Oct. 29, 2021 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) will release its third quarter 2021 financial results before the market opens on Tuesday, Nov. 9, 2021. Following the release, management will host a conference call at 10:00 a.m. ET to discuss the financial results and other matters. The conference call can be accessed as follows: By dialing 1-877-407-3982 (domestic) or 1-201-493-6780 (international) and requesting the ADT Third Quarter 2021 Earnings Conference Call Live webcast accessed through ADT’s website at investor.adt.com An audio replay of the conference call will be available from approximately 1:00 p.m. ET on Nov. 9, 2021, until 11:59 p.m. ET on Nov. 23, 2021, and can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international), and providing the passcode, 13724615 or by accessing...

NorthEast Community Bancorp, Inc. Reports Results for the Quarter Ended September 30, 2021

Written by Customer Service on October 29, 2021. Posted in Public Companies.

WHITE PLAINS, N.Y., Oct. 29, 2021 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (Nasdaq: NECB) (the “Company”), the parent holding company of NorthEast Community Bank (the “Bank”), reported net income of $730,000 and $7.7 million, or $0.05 and $0.48 per basic and diluted common share, for the three months and nine months ended September 30, 2021, respectively, compared to net income of $3.1 million and $8.9 million, or $0.26 and $0.74 per basic and diluted common share, for the three months and nine months ended September 30, 2020, respectively. Kenneth A. Martinek, NorthEast Community Bancorp’s Chairman of the Board and Chief Executive Officer, stated “Although we generated net income of $730,000 for the quarter, we are pleased to report that the performance of our loan portfolio remains strong with no loans past due and...

Month: October 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice